SweetGoals App for Type 1 Diabetes
Trial Summary
What is the purpose of this trial?
The study will test an app and web-delivered intervention designed to improve glycemic control (HbA1c) among young adults with Type 1 diabetes. All participants will receive the "core" digital intervention, the SweetGoals app, focused on self-monitoring and goal setting. Efficacy of two independent intervention components (incentives for adherence and web health coaching) will be tested
Research Team
Catherine Stanger, Ph.D.
Principal Investigator
Trustees of Dartmouth College
Eligibility Criteria
This trial is for young adults with Type 1 diabetes who have had the condition for over 18 months and an A1c level of at least 7.5%. They must have seen their diabetes doctor in the last six months and use a glucose monitor compatible with Glooko. It's not for pregnant or breastfeeding individuals, those with severe illnesses like cystic fibrosis, severe cognitive issues, psychiatric conditions that affect participation, other types of diabetes, or if they're on certain meds that affect blood sugar.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the SweetGoals app intervention, with some receiving additional incentives or coaching
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Coaching
- Incentives
- SweetGoals app
Find a Clinic Near You
Who Is Running the Clinical Trial?
Trustees of Dartmouth College
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator